[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE286716T1 - Pharmazeutische formulierungen enthaltend salmeterol - Google Patents

Pharmazeutische formulierungen enthaltend salmeterol

Info

Publication number
ATE286716T1
ATE286716T1 AT00977707T AT00977707T ATE286716T1 AT E286716 T1 ATE286716 T1 AT E286716T1 AT 00977707 T AT00977707 T AT 00977707T AT 00977707 T AT00977707 T AT 00977707T AT E286716 T1 ATE286716 T1 AT E286716T1
Authority
AT
Austria
Prior art keywords
pharmaceutical formulations
formulations containing
salmeterol
containing salmeterol
pharmaceutically acceptable
Prior art date
Application number
AT00977707T
Other languages
English (en)
Inventor
Alan Leslie Cripps
Paul Johnson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9927685.9A external-priority patent/GB9927685D0/en
Priority claimed from GBGB9930700.1A external-priority patent/GB9930700D0/en
Priority claimed from GB0014424A external-priority patent/GB0014424D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE286716T1 publication Critical patent/ATE286716T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00977707T 1999-11-23 2000-11-23 Pharmazeutische formulierungen enthaltend salmeterol ATE286716T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9927685.9A GB9927685D0 (en) 1999-11-23 1999-11-23 Pharmaceutical formulation
GBGB9930700.1A GB9930700D0 (en) 1999-12-24 1999-12-24 Pharmaceutical formulation
GB0014424A GB0014424D0 (en) 2000-06-13 2000-06-13 Pharmaceutical formulation
PCT/GB2000/004465 WO2001037805A1 (en) 1999-11-23 2000-11-23 Pharmaceutical formulations of salmeterol

Publications (1)

Publication Number Publication Date
ATE286716T1 true ATE286716T1 (de) 2005-01-15

Family

ID=27255759

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00977707T ATE286716T1 (de) 1999-11-23 2000-11-23 Pharmazeutische formulierungen enthaltend salmeterol

Country Status (7)

Country Link
EP (2) EP1523976A3 (de)
JP (1) JP2003514841A (de)
AT (1) ATE286716T1 (de)
AU (1) AU1534501A (de)
DE (1) DE60017450T2 (de)
ES (1) ES2234694T3 (de)
WO (1) WO2001037805A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019342A2 (en) 1999-09-11 2001-03-22 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
JP5082033B2 (ja) 2001-12-21 2012-11-28 エグゼリクシス パテント カンパニー エルエルシー Ｌｘｒのモジュレーター

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US6254882B1 (en) * 1997-09-16 2001-07-03 Sepracor Inc. Methods and compositions for treating pulmonary disorders using optically pure (S)—salmeterol
GB9808802D0 (en) * 1998-04-24 1998-06-24 Glaxo Group Ltd Pharmaceutical formulations
ATE253896T1 (de) * 1998-06-18 2003-11-15 Boehringer Ingelheim Pharma Zwei oder mehrere wirkstoffe enthaltende pharmazeutische aerosolformulierungen
ATE291898T1 (de) * 1999-12-24 2005-04-15 Glaxo Group Ltd Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
CA2411047C (en) * 2000-05-22 2009-08-04 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurised metered dose inhalers
DE10056104A1 (de) * 2000-11-13 2002-05-23 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols

Also Published As

Publication number Publication date
AU1534501A (en) 2001-06-04
JP2003514841A (ja) 2003-04-22
EP1523976A3 (de) 2005-06-22
EP1231894A1 (de) 2002-08-21
EP1231894B1 (de) 2005-01-12
DE60017450T2 (de) 2006-03-02
EP1523976A2 (de) 2005-04-20
DE60017450D1 (de) 2005-02-17
ES2234694T3 (es) 2005-07-01
WO2001037805A1 (en) 2001-05-31

Similar Documents

Publication Publication Date Title
ATE291898T1 (de) Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
DE60031504D1 (de) Fluticasonpropionat arzneizubereitung
NZ298169A (en) Aerosol drug formulation; comprises hydrofluoroalkane propellant, medicament for inhalation and a surfactant
CA2111002A1 (en) Non-Chlorofluorocarbon Aerosol Formulations
WO2001062227A3 (en) Anticholinergic drug formulations for treatment of chronic obstr uctive pulmonary disease
ATE342053T1 (de) Formulierungen zur inhalation
DE122011100049I1 (de) Stabile pharmazeutische Losungsformulierungen fur unter Druck stehende Inhaliergerate fur die Verabreichung abgemessener Dosen.
MY118151A (en) Pharmaceutical formulations containing voriconazole.
CA2004598A1 (en) Medicinal aerosol formulations
ATE228823T1 (de) Pharmazeutische aerosolformulierung
PT1123120E (pt) Formulacao medicinal em aerossol
CY1112562T1 (el) Φαρμακευτικες συνθεσεις για τη στοματικη χορηγηση της καλσιτονινης
WO2000041681A3 (de) ARZNEIFORMULIERUNGEN ENTHALTEND EIN OPIOID UND EINEN α-AGONISTEN
DE69828817D1 (de) Pharmazeutische aerosolzusammensetzungen
WO1999055332A8 (fr) Compositions medicinales
IL159217A0 (en) An oral pharmaceutical formulation comprising a basic pharmaceutically active ingredient having ph-dependent solubility, a process for the manufacture thereof and use thereof in medicine
GB0016876D0 (en) Novel formulation
ATE286716T1 (de) Pharmazeutische formulierungen enthaltend salmeterol
WO2002000191A3 (de) Bdellosomen
WO2002007672A3 (en) A medicinal aerosol formulation
PL357466A1 (en) Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
AU2827500A (en) Fluorinated chalcone derivatives or salts thereof and drugs containing the same as the active ingredient
GB0006897D0 (en) Medicaments
AU2001287930A1 (en) Pharmaceutical formulation for pulmonary or nasal administration
CA2446562A1 (en) Pharmaceutical formulation of fluticasone propionate

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties